Literature DB >> 18416789

A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settings.

John A Baker1, Karina Lovell, Neil Harris.   

Abstract

AIMS AND
OBJECTIVES: This paper aims to synthesise published literature of drug use/administration studies of pro re nata psychotropic medications in mental health wards.
DESIGN: The study employed a best-evidence synthesis review design.
BACKGROUND: The administration of psychotropic pro re nata medications is a frequently used clinical intervention in mental health wards. Pro re nata contributes to exposing patients to high doses of antipsychotic medication. Despite the frequent use of pro re nata, there is limited evidence of their effectiveness.
METHODS: A best-evidence synthesis review.
RESULTS: Six major themes emerged from the literature: (i) frequency of administration; (ii) administration during the 24-hour day; (iii) administration associated with length and stage of admission; (iv) rationales for administration; (v) medicines administered (including route of administration); and (vi) effects and side effects of the medicines administered.
CONCLUSIONS: Overall findings indicate that the administration of psychotropic pro re nata varies radically and appears to be influenced by many variables. Relevance to clinical practice. Patients are most likely to receive a benzodiazepine or typical antipsychotic as pro re nata. Pro re nata is an important and under-researched clinical intervention used in mental health wards.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18416789     DOI: 10.1111/j.1365-2702.2007.02236.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  9 in total

1.  Patterns of opiate, benzodiazepine, and antipsychotic drug dosing in older patients in a medical intensive care unit.

Authors:  Margaret A Pisani; Kyle Bramley; Michael T Vest; Kathleen M Akgün; Katy L B Araujo; Terrence E Murphy
Journal:  Am J Crit Care       Date:  2013-09       Impact factor: 2.228

2.  Effects of a recovery-oriented cognitive therapy training program on inpatient staff attitudes and incidents of seclusion and restraint.

Authors:  Nadine A Chang; Paul M Grant; Lauren Luther; Aaron T Beck
Journal:  Community Ment Health J       Date:  2013-12-12

3.  Bayesian time-series analysis of a repeated-measures poisson outcome with excess zeroes.

Authors:  Terrence E Murphy; Peter H Van Ness; Katy L B Araujo; Margaret A Pisani
Journal:  Am J Epidemiol       Date:  2011-10-24       Impact factor: 4.897

4.  Pro Re Nata Prescription and Perception Difference between Doctors and Nurses.

Authors:  Se Hwa Oh; Ji Eun Woo; Dong Woo Lee; Won Cheol Choi; Jong Lull Yoon; Mee Young Kim
Journal:  Korean J Fam Med       Date:  2014-07-25

5.  Does accreditation improve pro re nata benzodiazepines administration in psychiatric inpatients? Pre-post accreditation medical record comparison.

Authors:  Mohammed Abdullah Al-Sughayir
Journal:  Int J Ment Health Syst       Date:  2017-02-02

6.  Mobile Mindfulness Intervention on an Acute Psychiatric Unit: Feasibility and Acceptability Study.

Authors:  Lisa A Mistler; Dror Ben-Zeev; Elizabeth Carpenter-Song; Mary F Brunette; Matthew J Friedman
Journal:  JMIR Ment Health       Date:  2017-08-21

7.  Practical Considerations of PRN Medicines Management: An Integrative Systematic Review.

Authors:  Abbas Mardani; Piret Paal; Christiane Weck; Shazia Jamshed; Mojtaba Vaismoradi
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

8.  The medication process in a psychiatric hospital: are errors a potential threat to patient safety?

Authors:  Ann Lykkegaard Soerensen; Marianne Lisby; Lars Peter Nielsen; Birgitte Klindt Poulsen; Jan Mainz
Journal:  Risk Manag Healthc Policy       Date:  2013-09-09

9.  An Empirical Method of Detecting Time-Dependent Confounding: An Observational Study of Next Day Delirium in a Medical ICU.

Authors:  T E Murphy; P H Van Ness; K L B Araujo; M A Pisani
Journal:  Int J Stat Med Res       Date:  2016-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.